These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36917553)

  • 21. High-resolution MS in regulated bioanalysis: where are we now and where do we go from here?
    Fung EN; Jemal M; Aubry AF
    Bioanalysis; 2013 May; 5(10):1277-84. PubMed ID: 23721448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current advances and strategies towards fully automated sample preparation for regulated LC-MS/MS bioanalysis.
    Zheng N; Jiang H; Zeng J
    Bioanalysis; 2014 Sep; 6(18):2441-59. PubMed ID: 25384595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.
    Chovan LE; Black-Schaefer C; Dandliker PJ; Lau YY
    Rapid Commun Mass Spectrom; 2004; 18(24):3105-12. PubMed ID: 15565734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-speed gradient parallel liquid chromatography/tandem mass spectrometry with fully automated sample preparation for bioanalysis: 30 seconds per sample from plasma.
    Deng Y; Wu JT; Lloyd TL; Chi CL; Olah TV; Unger SE
    Rapid Commun Mass Spectrom; 2002; 16(11):1116-23. PubMed ID: 11992516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery.
    Ackermann BL; Berna MJ; Murphy AT
    Curr Top Med Chem; 2002 Jan; 2(1):53-66. PubMed ID: 11899065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample reduction strategies in discovery bioanalysis.
    Cai X; Zhang J; Shou WZ
    Bioanalysis; 2013 Jul; 5(13):1691-701. PubMed ID: 23822131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform.
    Liu R; Hoffpauir B; Chilewski SD; Gamberdella J; Kavita U; Duo J; Gleason C; Zhang Y; Pillutla R; DeSilva B; Hamuro L
    AAPS J; 2017 Jan; 19(1):82-91. PubMed ID: 27796911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery.
    Srinivasan B; Flórez Weidinger JD; Zhai X; Lemercier G; Ikeda T; Brewer M; Zhang B; Heyse S; Wingfield J; Steigele S
    SLAS Discov; 2022 Dec; 27(8):460-470. PubMed ID: 36156314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher throughput bioanalysis by automation of a protein precipitation assay using a 96-well format with detection by LC-MS/MS.
    Watt AP; Morrison D; Locker KL; Evans DC
    Anal Chem; 2000 Mar; 72(5):979-84. PubMed ID: 10739201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS.
    Ramanathan R; Jemal M; Ramagiri S; Xia YQ; Humpreys WG; Olah T; Korfmacher WA
    J Mass Spectrom; 2011 Jun; 46(6):595-601. PubMed ID: 21630388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in high-throughput mass spectrometry in drug discovery.
    Dueñas ME; Peltier-Heap RE; Leveridge M; Annan RS; Büttner FH; Trost M
    EMBO Mol Med; 2023 Jan; 15(1):e14850. PubMed ID: 36515561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gas pressure assisted microliquid-liquid extraction coupled online to direct infusion mass spectrometry: a new automated screening platform for bioanalysis.
    Raterink RJ; Witkam Y; Vreeken RJ; Ramautar R; Hankemeier T
    Anal Chem; 2014 Oct; 86(20):10323-30. PubMed ID: 25243401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated sample preparation and LC-MS for high-throughput ADME quantification.
    O'Connor D
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):52-8. PubMed ID: 11865673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Separation and sample pre-treatment in bioanalysis using monolithic phases: A review.
    Saunders KC; Ghanem A; Boon Hon W; Hilder EF; Haddad PR
    Anal Chim Acta; 2009 Oct; 652(1-2):22-31. PubMed ID: 19786168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acoustic ejection mass spectrometry: fundamentals and applications in high-throughput drug discovery.
    Liu C
    Expert Opin Drug Discov; 2022 Jul; 17(7):775-787. PubMed ID: 35635049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acoustic Ejection Mass Spectrometry: A Fully Automatable Technology for High-Throughput Screening in Drug Discovery.
    Simon RP; Häbe TT; Ries R; Winter M; Wang Y; Fernández-Montalván A; Bischoff D; Runge F; Reindl W; Luippold AH; Büttner FH
    SLAS Discov; 2021 Sep; 26(8):961-973. PubMed ID: 34308708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inductively coupled plasma-MS in drug development: bioanalytical aspects and applications.
    van Heuveln F; Meijering H; Wieling J
    Bioanalysis; 2012 Aug; 4(15):1933-65. PubMed ID: 22943623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated sample collection and handling for drug discovery bioanalysis.
    Zhang N; Rogers K; Gajda K; Kagel JR; Rossi DT
    J Pharm Biomed Anal; 2000 Aug; 23(2-3):551-60. PubMed ID: 10933549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advancing automation in high-throughput screening: Modular unguarded systems enable adaptable drug discovery.
    Hansel CS; Plant DL; Holdgate GA; Collier MJ; Plant H
    Drug Discov Today; 2022 Aug; 27(8):2051-2056. PubMed ID: 35304338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery.
    Ekert JE; Deakyne J; Pribul-Allen P; Terry R; Schofield C; Jeong CG; Storey J; Mohamet L; Francis J; Naidoo A; Amador A; Klein JL; Rowan W
    SLAS Discov; 2020 Dec; 25(10):1174-1190. PubMed ID: 32495689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.